Wellington Management Group LLP Akero Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 5,936,240 shares of AKRO stock, worth $300 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,936,240

Holding current value

$300 Million

% of portfolio

0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$21.87 - $57.56 $130 Million - $342 Million	5,936,240 New	5,936,240 $240 Million
Q4 2024 Feb 12, 2025	SELL	$26.75 - $35.28 $13.9 Million - $18.3 Million	-519,671 Reduced 6.58%	7,376,961 $205 Million
Q3 2024 Nov 14, 2024	BUY	$21.45 - $29.34 $59.7 Million - $81.6 Million	2,782,029 Added 54.39%	7,896,632 $227 Million
Q2 2024 Aug 13, 2024	SELL	$18.31 - $24.62 $1.81 Million - $2.43 Million	-98,761 Reduced 1.89%	5,114,603 $120 Million
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $92.6 Million - $163 Million	5,213,364 New	5,213,364 $132 Million
Q4 2023 Feb 12, 2024	BUY	$11.38 - $50.33 $32.8 Million - $145 Million	2,881,989 New	2,881,989 $67.3 Million
Q3 2023 Nov 14, 2023	SELL	$41.19 - $52.25 $2.98 Million - $3.77 Million	-72,244 Reduced 8.02%	828,961 $41.9 Million
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $9.57 Million - $14.8 Million	-259,337 Reduced 22.35%	901,205 $42.1 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $50.24 $10.6 Million - $14.3 Million	284,443 Added 32.47%	1,160,542 $44.4 Million
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $2.66 Million - $4.36 Million	79,600 Added 9.99%	876,099 $48 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $954,292 - $3.2 Million	94,019 Added 13.38%	796,499 $27.1 Million
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $12.2 Million - $23 Million	-1,530,043 Reduced 68.53%	702,480 $6.64 Million
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $4.61 Million - $7.92 Million	355,712 Added 18.95%	2,232,523 $31.7 Million
Q4 2021 Feb 11, 2022	SELL	$19.87 - $26.24 $606,372 - $800,766	-30,517 Reduced 1.6%	1,876,811 $39.7 Million
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $4.8 Million - $6.56 Million	257,638 Added 15.62%	1,907,328 $42.6 Million
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $2.64 Million - $3.44 Million	106,360 Added 6.89%	1,649,690 $40.9 Million
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $3.06 Million - $4.35 Million	-127,180 Reduced 7.61%	1,543,330 $44.8 Million
Q4 2020 Feb 12, 2021	SELL	$25.12 - $29.89 $3.06 Million - $3.64 Million	-121,803 Reduced 6.8%	1,670,510 $43.1 Million
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $54.9 Million - $71.2 Million	1,784,115 Added 21762.81%	1,792,313 $55.2 Million
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $157,811 - $219,378	8,198 New	8,198 $204,000
Q1 2020 May 14, 2020	SELL	$12.8 - $27.05 $3.15 Million - $6.66 Million	-246,301 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$17.37 - $27.27 $4.28 Million - $6.72 Million	246,301 New	246,301 $5.47 Million

Others Institutions Holding AKRO

# of Institutions

279

Shares Held

85.4M

Call Options Held

Put Options Held

720K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.34B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Akero Therapeutics, Inc. Transaction History